JAZZ Financial Facts

Net income (loss): 55.29M
Total revenues: 235.77M
See Full Income Statement

Total stockholders' equity: 1.3B
Total current liabilities: 204.03M
See Full Balance Sheet

Jazz Pharmaceuticals, Inc. (JAZZ) Earnings

  |   Expand Research on JAZZ
Next EPS Date 5/8/14 *Est. EPS Growth Rate +12.4% *Last Qtr.
Average EPS % Beat Rate -0.3% Revenue Growth Rate +28.4% *Last Qtr.
Average % Move 1-Wk after EPS +1.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
11/4/10 Q310 $0.41$0.34 +$0.07N/AN/A N/A +1072.2% Details
3/7/11 Q410 $0.63$0.60 +$0.03$53.4M$51.05M +433.8% Details
11/5/13 Q313 $1.78$1.67 +$0.11$232.2M$227.38M = +56.2% Details
8/6/13 Q213 $1.43$1.52 -$0.09$208.3M$208.71M = +86.5% Details
2/26/13 Q412 $1.53$1.42 +$0.11$183.7M$183.8M = +154.9% Details
7/28/11 Q211 $0.82$0.77 +$0.05$64.6M$61.86M +312.1% Details
2/27/12 Q411 $1.17$1.09 +$0.08$83.5M$80.84M = +187.7% Details
5/7/13 Q113 $1.37$1.35 +$0.02$196.2M$189.92M = +144.3% Details